DOCSLIB.ORG

S.No. Name ISSN No. Publisher Impact Factor Indexed in 1 Journal

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
S.No. Name ISSN No. Publisher Impact Factor Indexed in 1 Journal List of Journals S.No. Name ISSN No. Publisher Impact Indexed in Factor 1 Journal of Molecular Catalysis B: 1381-1177 ELSEVIER 2.805 EMBASE, Scopus Enzymatic 2 International Journal of Pharmacy and 0975-1491 Innovare Academic 1.59 Google Scholar, Scopus, Elsevier, EBSCO, EMBASE Pharmaceutical Sciences Sciences 3 The Federation of European 1742-4658 Wiley Online library 4.25 Google Scholar, Scopus, Elsevier, EBSCO, EMBASE Biochemical Societies (FEBS) Journal 4 Future Medicinal Chemistry 2320-5148 Future Group 3.31 EMBASE/Excerpta Medica, Journal Citation Reports/Science edition, MEDLINE/Index Medicus, Science Citation Index Expanded, Scopus 5 Pharmaceutical Patent Analyst 0976-044X Future Group NIL Chemical Abstracts, EMBASE/Excerpta Medica, MEDLINE/Index Medicus 6 Current Medicinal Chemistry 0929-8673 Bentham Science Publisher 4.07 CAS, Embase, Pubmed, MEDLINE, Biobase 7 Current Computer Aided Drug Design 15734099 Bentham Science Publisher 1.54 CAS, Embase, Pubmed, MEDLINE, Biobase 8 Journal of Enzyme Inhibition and 1475-6366 Informa Healthcare 1.495 CAS, Embase, Pubmed, MEDLINE, Biobase Medicinal Chemistry 9 Expert Opinion on Therapeutic Patents 1354-3776 Informa Healthcare 3.525 CAS, Embase, Pubmed, MEDLINE, Biobase 10 Organic and Biomolecular Chemistry 1477-0520 Royal Society of Chemistry 3.568 CAS, Embase, Pubmed, MEDLINE, Biobase 11 Med ChemComm 2040-2503 Royal Society of Chemistry 2.722 CAS, Embase, Pubmed, MEDLINE, Biobase 12 Letters in Drug Design and Discovery 1570-1808 Bentham Science Publisher 0.845 CAS, Embase, Pubmed, MEDLINE, Biobase 13 Annual Reports in Medicinal 0065-7743 American Chemical Society 1.61 CAS, Embase, Pubmed, MEDLINE, Biobase Chemistry 14 Drug Development Research 1098-2299 Wiley Online Library 0.869 CAS, Embase, Pubmed, MEDLINE, Biobase 15 Bioorganic and Medicinal Chemistry 0960-894X Elsevier 2.338 CAS, Embase, Pubmed, MEDLINE, Biobase Letters 16 Journal of Combinatorial Chemistry 1520-4774 American Chemical Society 4.93 CAS, Embase, Pubmed, MEDLINE, Biobase 17 Steroids 0039-128X Elsevier 2.739 CAS, Embase, Pubmed, MEDLINE, Biobase 18 Current Organic Chemistry 1385-2728 Bentham Science Publisher 3.039 CAS, Embase, Pubmed, MEDLINE, Biobase Page 1 S.No. Name ISSN No. Publisher Impact Indexed in Factor 19 Indian Journal of Chemistry: Section B 0376-4699 INSA, CSIR (India), 0.69 CAS, Embase, Pubmed, MEDLINE, Biobase NISCIR (New Delhi, India) 20 European Journal of Medicinal 0223-5234 Elsevier 3.499 CAS, Embase, Pubmed, MEDLINE, Biobase Chemistry 21 Medicinal Chemistry Research 1054-2523 Springer Publication 1.612 CAS, Embase, Pubmed, MEDLINE, Biobase 22 Journal of Medicinal Chemistry 0022-2623 American Chemical Society 5.614 CAS, Embase, Pubmed, MEDLINE, Biobase 23 Mini reviews in Medicinal Chemistry 1389-5575 Bentham Science Publisher 2.865 CAS, Embase, Pubmed, MEDLINE, Biobase 24 Molecular Informatics 1868-1751 Wiley Online Library 2.338 CAS, Embase, Pubmed, MEDLINE, Biobase 25 Archives of Pharmacal Research 0253-6269 Springer Publication 1.538 CAS, Embase, Pubmed, MEDLINE, Biobase 26 Chemical and Pharmaceutical Bulletin Nihon Yakugakkai 1.56 CAS, Embase, Pubmed, MEDLINE, Biobase 27 ChemMedChem 0009-2363 Wiley Online Library 3.075 CAS, Embase, Pubmed, MEDLINE, Biobase 28 Chemical Reviews Print Edition American Chemical Society 41.298 CAS, British Library, CABI, EBSCOhost, Proquest, ISSN: 0009- PubMed, SCOPUS, SwetsWise, Web of Science. 2665, Web Edition ISSN: 1520-6890 29 Evidence-Based Complementary and 1741-4288 Hindawi 1.722 Pub Med Alternative Medicine 30 Indian Journal of Medical Research 0971-5916 ICMR and Medknow 2.061 Index Copernicus 31 Journal of Medicinal Food 1096-620X Liebert Publications 1.642 Scopus 32 Journal of Ethnopharmacology 1872-7573 Elsevier 2.775 Scopus 33 Pharmaceutical Biology 1388-0209 Informa Healthcare 0.878 MEDLINE 34 Indian Journal of Clinical 0970-1915 Springer --- Pub Med Biochemistry 35 Toxicology Letters 0378-4274 Elsevier 3.145 MEDLINE 36 Toxicology & Applied Pharmacology 0041-008X Elsevier 3.975 Medicus 37 Vascular Pharmacology 1537-1891 Elsevier 2.174 MEDLINE Page 2 S.No. Name ISSN No. Publisher Impact Indexed in Factor 38 Toxicology International 0971-6580 Society of Toxicology --- Scopus 39 Diabetes and Vascular Disease 1479-1641 Sage Publications 2.594 MEDLINE Research 40 Journal of Complimentary & 1075-5535 Liebert Publications 1.464 MEDLINE Alternative Medicine 41 Pharmacology Biochemistry and 0091-3057 Elsevier 2.068 Pub Med Behaviour 42 Asia Pacific Journal of Tropical 1995-7645 Elsevier 0.502 Pub Med Medicine 43 Indian Journal of Pain 0970-5333 Medknow -- Index Copernicus 44 Indian Journal of Pharmaceutical 0250474X Medknow 0.626 Pub Med Sciences 45 Indian Journal of Pharmacology 0253-7613 Medknow 0.583 Pub Med 46 Journal of Pharmacology and 0976-500X Medknow -- Pub Med Pharmacotherapeutics 47 Pharmacognosy Research 0976-4836 Medknow -- Pub Med 48 Pharmacological reports 1734-1140 Polish Academy of 2.445 Index Copernicus Sciences 49 BMC Complementary and Alternative 1472-6882 Biomed Central 2.08 Pub Med Medicine 50 Behavioral and Brain functions 17449081 Biomed Central 2.79 Pub Med 51 Indian Journal of Experimental 0019-5189 NISCAIR 1.195 Pub Med Biology 52 International Journal of Neuroscience 0020-7454 Informa Healthcare 1.216 Pub Med 53 Indian Journal of Pharmaceutical 0019-5464 APTI 0.15 Scopus Education and Research 54 Indian Journal of Physiology and 0019-5499 APPI -- MEDLINE Pharmacology 55 International Journal of 0736-5748 Elsevier 2.692 Embase Developmental Neuroscience Page 3 S.No. Name ISSN No. Publisher Impact Indexed in Factor 56 ISRN Pharmacology 2090-5165 International Scholarly ---- Pub Med Central Research Network 57 International Journal of Pharmacology 1811-7775 Science alert -- Scopus 58 Journal of Advanced 2231-4040 Medknow 1.093 Pub Med Central Pharmatechnology and Research 59 American Journal of Phytomedicine 2321-2748 Pubicon 0.569 Index Copernicus and Clinical Therapeutics 60 International Journal of 2249-6084 Elsevier 0.7826 EMBASE Pharmaceutical and 61 LifePhytopharmacological science Research 0024-3205 Elsevier 2.55 Google Scholar 62 Journal of Ayurveda and integrative 0976-2309 Research gate --- Google Scholar medicine 63 Current opinion in pharmacology 1471-4892 Elsevier 5.44 Sci direct 64 European journal of pharmacology 0014-2999 Elsevier 2.59 Pubmed 65 International journal of hypertension 0950-9240 Hindawi -- Scopus 66 Advances in pharmacological science 1687-6334 Hindawi -- Scopus 67 Food and chemical toxicology 0278-6915 Elsevier 3.01 MEDLINE 68 International journal of basic and 2319-2003 Medip --- MEDLINE clinical pharmacology 69 Neuropharmacology 0028-3908 Elsevier 4.114 MEDLINE 70 Pharmacological research 1043-6618 Elsevier 4.346 MEDLINE 71 International journal of pharmacology 1812-5700 Research gate 1.2 MEDLINE 72 Pharmacology research and 2052-1707 Willy -- MEDLINE prospective 73 Journal of cardiovascular 1074-2484 SAGE 1.97 Embase, MEDLINE pharmacology and therapeutics 74 Journal of cardiovascular 0166-2446 Research gate 2.59 Pubmed pharmacology Page 4 S.No. Name ISSN No. Publisher Impact Indexed in Factor 75 Cardiovascular pharmacology 2329-6607 Lippincott,Williams, -- Pubmed Wilkins 76 Cardiovascular drugs and therapy 0920-3200 Springer 2.673 Sci-citation 77 Pharmaceutical biology 1388-0209 Informa-health care 1.06 MEDLINE 78 Journal of membrane biology 0022-2631 Springer 2.478 Sci-citation 79 Epilepsy and behavior 1525-5050 Elsevier 1.844 Pubmed 80 Epilepsy research 0920-1211 Elsevier 2.241 Pubmed 81 Seizures-European journal of epilepsy 1059-2311 Elsevier 2.004 Pubmed 82 Current opinion in neurobiology 0959-4388 Elsevier 7.335 Pubmed 83 Brain research 0006-8993 Elsevier 2.872 Pubmed 84 Molecular Membrane Biology 0968-7688 Informa 2.346 Sci-citation 85 Drug Discovery today 1359-6446 Elsevier 6.551 MEDLINE 86 Biomicrofluidics 1932-1058 AIP Publishing LLC 3.385 AIP 87 Journal of Drug Delivery 2090-3022 Hindawi Publishing 5.91 PUBMED,EMBASE,EBSCO Discovery Service Corporation 88 Nanoscale 2040-3364 RSC publishing 4.1 Royal Society of Chemistry 89 Small 1613-6829 John Wiley & Sons, Inc. 7.3 MEDLINE 90 Biomaterials 2047-4830 Elsevier Inc. 9.07 PUBMED,EMBASE,EBSCO Discovery Service 91 Pharmaceutical Research 0724-8721 Springer 4.74 Science Citation Index,SCOPUS, INSPEC, EMBASE 92 Methods in Molecular Biology 1064-3745 Springer 1.29 Science Citation Index,SCOPUS, INSPEC, EMBASE 93 Bioconjugate Chemistry 043-1802 (Print) ACS publications 5.02 MEDLINE 1520-4812 (Electronic) 1043-1802 (Linking) Page 5 S.No. Name ISSN No. Publisher Impact Indexed in Factor 94 Macromolecular Bioscience 1616-5187 John Wiley & Sons, Inc. 3.4 MEDLINE (Print) 1616-5195 (Electronic) 1616-5187 (Linking) 95 Journal of Control Release 0168-3659 Elsevier Inc. 7.16 MEDLINE (Print) 1873-4995 (Electronic) 0168-3659 (Linking) 96 Progress in Polymer Sciences 0079-6700 Elsevier Inc. 22.87 PUBMED,EMBASE,EBSCO Discovery Service 97 Molecular Pharmaeutics 1543-8384 ACS publications 4.5 MEDLINE 98 IET Nanobiotechnology 1751-8741 IET digital library 1 MEDLINE 99 Journal of Biomedical 1550-7033 American Scientific 5.256 MEDLINE Nanotechnology (JBN) (Print) Publishers. 1550-7041 (Electronic) 1550-7033 (Linking) 100 Journal of Pharmaceutical Sciences 1520-6017 John Wiley & Sons, Inc. 3.13 PUBMED,EMBASE,EBSCO 101 European Journal of Pharmaceutical 0939-6411 Elsevier Inc. 2.987 PUBMED,EMBASE,EBSCO Discovery Service Sciences 102 Carbon 0008-6223 Elsevier Inc. 5.868 PUBMED,EMBASE,EBSCO Discovery Service 103 Advanced Drug Delivery Reviews 0169-409X Elsevier
Load more

Recommended publications
  • Brian O'neal Bachmann, Ph.D
    Prepared: January 5, 2011 BRIAN O’NEAL BACHMANN, PH.D. Departments of Chemistry and Biochemistry Vanderbilt University Nashville, TN 37235-1822 Phone: (615) 322-8865; Fax: (615) 343-1234 E-mail: [email protected] http://www.vanderbilt.edu/AnS/Chemistry/BachmannGroup/ DEGREES EARNED 1995 – 2000 The Johns Hopkins University, Baltimore, Maryland. Ph.D. degree in Chemistry, December, 2000. Dissertation entitled: Identification and Characterization of β−Lactam Synthetase of Clavulanic Acid Biosynthesis. Advisor: Professor Craig. A. Townsend 1993 – 1994 Southern Methodist University, Dallas, Texas. M.S. degree in Chemistry, December 1994. Thesis entitled: Synthesis and Evaluation of Mechanism Based β−lactamase Inhibitors. Advisor: Professor John D. Buynak 1988 – 1992 Virginia Tech, Blacksburg, Virginia. B.S. degree in Chemistry, December 1992. Undergraduate Research Advisor: Tomas Hudlicky EMPLOYMENT HISTORY 2000 – 2001 Postdoctoral Fellow, The Johns Hopkins University Department of Chemistry, Baltimore, Maryland 2001 – 2002 Assistant Director of Chemistry, Ecopia Biosciences (now Thallion Pharmaceuticals), Montreal, Quebec, Canada 2002 – 2003 Director of Chemistry, Ecopia Biosciences (now Thallion Pharmaceuticals), Montreal, Quebec, Canada 2003 – current Assistant Professor of Chemistry, Vanderbilt University Department of Chemistry, Nashville, Tennessee 2000 – current Director, Board of Directors, Dymax Corporation, Torrington, Connecticut HONORS AND AWARDS • American Society of Chemists: Outstanding Graduate Student in Chemistry,
    [Show full text]
  • Issn 0975-413X Coden (Usa): Pchhax
    Available online a t www.derpharmachemica.com ISSN 0975-413X Der Pharma Chemica, 2016, 8(19):388-395 CODEN (USA): PCHHAX (http://derpharmachemica.com/archive.html) Design and Modification of Copper Oxide Electrodes for Improving Conversion Coefficient Indoors Lights (PV-Cell) Photocells Rahadian Zainul Department of Physical Chemistry, Universitas Negeri Padang, Padang, Indonesia _____________________________________________________________________________________________ ABSTRACT This research aims to investigate photocells reactor design can convert indoor lights energy into electrical energy. Indoor lights comes from sunlight entering into the room and fluorescent light irradiation. Design of photocells reactor use a panel of copper oxide (Cu 2O/CuO) of calcined Cu plate and filler electrolyte Na 2SO 4 0.5 N. Modification of electrode by n-p junction layer, which one of section (n) and the others section (p). Photocells reactor was constructed by thickness of the glass pane, the distance between the electrodes, the interface layer, layer and coating reflector panels. In this research there are three design of photocells reactor, The first design is R1, the thickness of the glass panel 3 mm thick reactor 15 mm without anti reflector. In this design, there are two type based on the difference at the junction of type n, (R 1a = plate Cu; R 1b = plate Aluminum) generate 182.82 2 2 mW/m and 21119644.3 NW/m . Than, the second design of photocells reactor is R2a (junction-type n = plate Cu) and R 2b (junction-type n = plate Al), a panel thickness of 15 mm and has a layer anti reflector provide power 214.95 2 2 mW/m and 24163298.3 NW/m .
    [Show full text]
  • Mosby's Comprehensive Review of Radiography
    PERPUSTAKAAN PRIBADI AN-NUR YOU’VE JUST PURCHASED MORE THAN A TEXTBOOK!* Evolve Student Resources for Callaway: Mosby’s Comprehensive Review of Radiography: The Complete Study Guide and Career Planner, Seventh Edition, include the following: • Radiography Practice Exams • Flashcards • Sample Resumes and Cover Letters Activate the complete learning experience that comes with each NEW textbook purchase by registering with your scratch-off access code at http://evolve.elsevier.com/Callaway/radiography/ If you purchased a used book and the scratch-off code at right has already been revealed, the code may have been used and cannot be re-used for registration. To purchase a new code to access these valuable study resources, simply follow the link above. Place Peel Off Sticker Here REGISTER TODAY! You can now purchase Elsevier products on Evolve! Go to evolve.elsevier.com/html/shop-promo.html to search and browse for products. * Evolve Student Resources are provided free with each NEW book purchase only. Mosby’s Comprehensive Review of Radiography The Complete Study Guide and Career Planner Seventh Edition This page intentionally left blank Mosby’s Comprehensive Review of Radiography The Complete Study Guide and Career Planner Seventh Edition William J. Callaway, MA, RT(R) Radiography Educator, Author, Speaker Springfield, Illinois 3251 Riverport Lane St. Louis, Missouri 63043 MOSBY’S COMPREHENSIVE REVIEW OF RADIOGRAPHY: THE COMPLETE STUDY GUIDE AND CAREER PLANNER, SEVENTH EDITION ISBN: 978-0-323-35423-3 Copyright © 2017 Elsevier Inc. All Rights Reserved. Previous editions copyrighted 2013, 2008, 2006, 2002, 2000, 1998, 1995. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher.
    [Show full text]
  • Exploring the Stability of Publication Regimes in Chemistry
    ARTICLE https://doi.org/10.1057/s41599-020-00543-6 OPEN Back to disciplines: exploring the stability of publication regimes in chemistry: the case of the Journal of the American Chemical Society (1879–2010) ✉ Marianne Noel1 1234567890():,; Based on a case study, this article explores the stability of publication regimes (as defined by Hilgartner (2015, 2017)) in chemistry. Starting with a slight detour via open access (OA) policies, it concentrates on the conditions of editorial production and trade of a scholarly journal, from an historical perspective enriched by a sociology of valuation and pricing. Prices are seen as social constructs as I consider the modalities of market coordination among actors of the publishing enterprise in a major scholarly society, the American Chemical Society (ACS). The study focuses on the Journal of the American Chemical Society (JACS), a periodical that was founded in 1879 by the ACS, of which it is the “flagship” journal. The investigation relies mainly on a detailed examination of the JACS imprint from a diachronic perspective (1879–2010). I describe how scientific papers (as singular entities) gradually entered into a commodity market, first with the page-charge mechanism and the imposition of authors’ fees, up to the emergence of the Article Processing Charge (APC) model, where the authors/institutions pay fees to have the electronic versions of their articles in OA. The proposed timeline in five periods is marked by two points of rupture that correspond to State intervention and the adoption of federal laws. Inherited from the deployment of science regimes in the post-WWII period, revenue collection models were collectively invented by the ACS and its members as successive adjustments to address massive imbalances caused by changes in scientific, institutional, and regulatory environments.
    [Show full text]
  • 2017 Elsevier Foundation Annual Report
    2017 Elsevier Foundation Report Médecins Sans Frontiers doctors conduct a Phase III rotavirus vaccine trial at Epicentre’s Niger Research Center at the Maradi Hospital, which receives an annual capacity building grant of $100,000 from the Elsevier Foundation. © KRISHAN Cheyenne/MSF White City students at a recent Imperial College London workshop with the student drone society. The Elsevier Foundation supported Maker’s Challenge space will launch in September, hosting future White City students as they navigate 3D printers, tackle robotics and many other tech challenges. © Imperial College London 2017 OWSD-Elsevier Foundation woman scientist award winner Felycia Edi Soetaredjo, PhD, Lecturer at Widya Mandala Surabaya Catholic University in Surabaya, Indonesia, was recognized for her work utilizing waste and cheap materials for environmental remediation of renewable energy. © Widya Mandala Surabaya Catholic University The Elsevier Foundation 2017 Board Report 2 Contents Foreword: Youngsuk “YS” Chi, President of the Elsevier Foundation I. The Elsevier Foundation 1. Who we are 2. Our Board 3. Our Programs 4. Our Future II. Our Programs 1. Health & Innovation 2. Research in Developing Countries 3. Diversity in STM 4. Technology for Development IV. Matching Gift V. Media Outreach VI. Financial Overview VII. Appendix The Elsevier Foundation 2017 Board Report 3 The Elsevier Foundation 2017 Board Report 4 Foreword On the occasion of the September 2017 Elsevier Foundation Board Meeting It has been an incredible privilege to steer collaboration in Sustainability. The TWAS the Elsevier Foundation’s development Elsevier Foundation Program provides over the last decade. I continue to be travel grants for PhD’s and postdoc inspired by the dedication and resolve of scientists studying in sustainability fields this group as we strive to tackle important and hosts case study competitions to global challenges.
    [Show full text]
  • Pharmaceutics (PCEU) 1
    Pharmaceutics (PCEU) 1 PCEU 615. Applied Pharmacokinetics. 2.5 Hours. PHARMACEUTICS (PCEU) Semester course; 2.5 lecture hours. 2.5 credits. Extends the concepts of pharmacokinetics as applied to dosage regimen design, pharmacokinetic PCEU 501. Pharmaceutical Calculations. 1 Hour. variability, drug interactions and statistical strategies for individualization Semester course; 1 lecture hour. 1 credit. This course is designed in a of drug therapy. Lectures and conferences take place throughout the student-centered learning format that supports self-directed learning. The semester. course will help students develop the skill set needed to screen out the PCEU 621. Advanced Pharmaceutics and Drug Disposition. 3 Hours. distractors from the determinant variables in a statement problem and Semester course; 3 lecture hours. 3 credits. Study at the advanced guide their thought processes in sequential use of information to solve level of the relationships between the physiochemical properties of a calculation problems seen in pharmacy practice. drug and dosage form and the absorption, distribution, elimination and PCEU 507. Pharmaceutics and Biopharmaceutics I. 3 Hours. pharmacological effects of the drug. Current theory and methodology Semester course; 3 lecture hours. 3 credits. Designed to describe involved in solving problems at the research level are emphasized. the physico-chemical and biopharmaceutical principles fundamental PCEU 622. Clinical Pharmacokinetics. 3 Hours. to the development of pharmaceutical dosage forms. Topics will Semester course; 2 lecture and 2 laboratory hours. 3 credits. The include pharmaceutical calculations, solid-state properties, solubility, application of current pharmacokinetic theory to clinical problems partitioning, solution properties, disperse systems, micromeritics, involved in optimizing and monitoring drug use in patients.
    [Show full text]
  • The Journal of Clinical Pharmacology
    The Journal of Clinical Pharmacology Activity Report Issues 47: 1 – 3 January – March 2007 Contents Circulation...................................................................................................................................................................3 Commercial Sales .......................................................................................................................................................5 Summary .................................................................................................................................................................................... 5 Commercial Reprints ................................................................................................................................................................ 6 Supplements .............................................................................................................................................................................. 7 Journal Activity Summary ........................................................................................................................................7 Production.................................................................................................................................................................................. 7 Abstracting & Indexing ............................................................................................................................................................ 8 Thomson Scientific
    [Show full text]
  • Journal of Biotechnology
    JOURNAL OF BIOTECHNOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 0168-1656 DESCRIPTION . Journal of Biotechnology provides a medium for the rapid publication of both full-length articles and short communications on novel and innovative aspects of biotechnology. The Journal will accept papers ranging from genetic or molecular biological positions to those covering biochemical, chemical or bioprocess engineering aspects as well as computer application of new software concepts, provided that in each case the material is directly relevant to biotechnological systems. Papers presenting information of a multidisciplinary nature that would not be suitable for publication in a journal devoted to a single discipline, are particularly welcome. The following areas are covered in the Journal: * Nucleic Acids/Molecular Biology * Physiology/Biochemistry * Biochemical Engineering/Bioprocess Engineering * Industrial Processes/New Products * Medical Biotechnology * Agro- and Food Biotechnology * Genomics and Bioinformatics More information on these areas can be foundhere Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center AUDIENCE . Microbiologists, Molecular Biologists, Environmental Scientists, Genetic Engineers. IMPACT FACTOR . 2020: 3.307 © Clarivate Analytics Journal Citation Reports 2021 AUTHOR INFORMATION PACK 28 Sep 2021 www.elsevier.com/locate/jbiotec 1 ABSTRACTING AND INDEXING .
    [Show full text]
  • Citation Success Index – an Intuitive Pair- Wise Journal Comparison Metric
    Citation success index – An intuitive pair- wise journal comparison metric Staša Milojević1, Filippo Radicchi1 and Judit Bar-Ilan2 1School of Informatics and Computing, Indiana University, Bloomington, USA 2Department of Information Science, Bar-Ilan University, Ramat Gan, 5290002, Israel In this paper we present “citation success index”, a metric for comparing the citation capacity of pairs of journals. Citation success index is the probability that a random paper in one journal has more citations than a random paper in another journal (50% means the two journals do equally well). Unlike the journal impact factor (IF), the citation success index depends on the broadness and the shape of citation distributions. Also, it is insensitive to sporadic highly-cited papers that skew the IF. Nevertheless, we show, based on 16,000 journals containing ~2.4 million articles, that the citation success index is a relatively tight function of the ratio of IFs of journals being compared, due to the fact that journals with same IF have quite similar citation distributions. The citation success index grows slowly as a function of IF ratio. It is substantial (>90%) only when the ratio of IFs exceeds ~6, whereas a factor of two difference in IF values translates into a modest advantage for the journal with higher IF (index of ~70%). We facilitate the wider adoption of this metric by providing an online calculator that takes as input parameters only the IFs of the pair of journals. 1. Introduction Most authors of research articles, whether in teams or as individuals, ultimately aim to maximize the impact of their publications, even when this goal is expressed as a desire to reach the widest possible audience (Gordon, 1984; Luukkonen, 1992).
    [Show full text]
  • Front Matter
    ANTICANCER RESEARCH International Journal of Cancer Research and Treatment ISSN: 0250-7005 Volume 40, Number 1, January 2020 Contents Review Current Treatment of Colorectal Liver Metastasis as a Chronic Disease. N.M. DÖRR, M. BARTELS, M.H. MORGUL (Leipzig; Münster, Germany) ......................................................................................................................... 1 Experimental Studies SAHA and EGCG Promote Apoptosis in Triple-negative Breast Cancer Cells, Possibly Through the Modulation of cIAP2. K.L. STEED, H.R. JORDAN, T.O. TOLLEFSBOL (Birmingham, AL, USA) .......................................... 9 Genetic Polymorphisms in IL-10 Promoter Are Associated With Smoking and Prostate Cancer Risk in African Americans. M. ABBAS, T. MASON, A. IBAD, M. KHRAIWESH, V. APPREY, Y. KANAAN, B. WILSON, G. DUNSTON, L. RICKS-SANTI, H. BRIM (Washington, DC; Silver Spring, MD; Hampton, VA, USA) ................. 27 High Expression of c-Met, PKC λ and ALDH1A3 Predicts a Poor Prognosis in Late-stage Breast Cancer. H. MOTOMURA, Y. NOZAKI, C. ONAGA, A. OZAKI, S. TAMORI, T.-A. SHIINA, S. KANAI, C. OHIRA, Y. HARA, Y. HARADA, R. TAKASAWA, T. HANAWA, S.-I. TANUMA, Y. MANO, T. SATO, K. SATO, K. AKIMOTO (Chiba, Japan) ............................................................................................................................................... 35 Targeting Fibroblast Growth Factor Receptor (FGFR) and Phosphoinositide 3-kinase (PI3K) Signaling Pathways in Medulloblastoma Cell Lines. S. HOLZHAUSER, M. LUKOSEVICIUTE,
    [Show full text]
  • Guidelines for Authors (Revised January 2010)
    Guidelines for Authors (Revised January 2010) Contents (click on the topic) Objectives – Articles – Brief Articles – Current Reviews – Communications | Editorial Organization | Preparation of Electronic Manuscripts | Assembly of Manuscripts – Author Checklist – Title Page – Table of Contents Graphic – Abstract – Keywords – Abbreviations – Introduction – Experimental Section – Results – Discussion – Acknowledgment – Supporting Information – References – Tables – Figure Captions – Illustrations: Figures, Schemes, etc. – Nomenclature – Software – Coordinate Deposition | Submission – Copyright | Publication – Proofs – “Just Accepted” Manuscripts – ASAP Publication – ACS Policies for E-prints and Reprints Objectives The purpose of Molecular Pharmaceutics is to publish the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Theoretical and experimental peer-reviewed communications, full-length research papers, brief articles, and critical reviews are welcomed. Submission of a manuscript to Molecular Pharmaceutics implies that the same work has not been previously published, including as part
    [Show full text]
  • Aacp Core List of Journals for Pharmacy Education
    AACP CORE LIST OF JOURNALS FOR PHARMACY EDUCATION 7th Edition, 2019 Prepared by: Robert D. Becketta, PharmD; Skye Bicketb, DHSc, MLIS; Kayce Gillc, MIS; Neyda Gilmand, MILS; Jason Guye, PharmD; Pam Hargwoodf, MLIS; Jennifer Hartmang, PharmD; Rebecca Hooverh; Tim Hutchersoni, PharmD; Jennifer Martinj, MIRLS; John Redwanskik, PharmD; Christina M. Seegerg, CPhT, MLS, AHIP Introduction The 7th edition of the AACP Core List of Journals for Pharmacy Education (Core Journals List) is a companion list to AACP Basic Resources for Pharmacy Education, and is an updated version of the 2016 Core Journals List. The update was conducted by an interdisciplinary task force of drug information specialists and pharmacy librarians. The goals for this update were to refine the previous list using similar, systematic collection methods. Similar to the previous update, the goal was to produce a final list containing 200 to 300 journals. The Core Journals List is a service project of the Library and Information Sciences Section of AACP. It is intended to provide information that assists with collection development as applied to the curriculum of the particular school or college of pharmacy for which it is being used. The Core Journals List is produced as a guide for those developing or maintaining the library collections that serve colleges and schools of pharmacy. While the recommended journals are suitable for all pharmacy college libraries, not all pharmacy college libraries should feel obligated to purchase every title on the list. Each pharmacy program has its own mission and program(s), so each college’s library’s collection must reflect that mission and support the college’s curricula.
    [Show full text]